PortfoliosLab logoPortfoliosLab logo
AYTU vs. PRGS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AYTU vs. PRGS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aytu BioPharma, Inc. (AYTU) and Progress Software Corporation (PRGS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AYTU achieves a -17.31% return, which is significantly higher than PRGS's -26.75% return.


AYTU

1D
-1.83%
1M
-4.44%
YTD
-17.31%
6M
-6.52%
1Y
10.26%
3Y*
6.50%
5Y*
-54.38%
10Y*

PRGS

1D
-0.38%
1M
19.34%
YTD
-26.75%
6M
-29.75%
1Y
-50.24%
3Y*
-19.45%
5Y*
-7.35%
10Y*
3.19%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AYTU vs. PRGS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AYTU
Aytu BioPharma, Inc.
-17.31%52.94%-40.14%-24.87%-86.00%-77.42%-38.35%22.41%-98.22%-89.38%
PRGS
Progress Software Corporation
-26.75%-34.06%21.16%8.94%6.05%8.44%10.64%18.95%-15.41%54.35%

Correlation

The correlation between AYTU and PRGS is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Feb 1, 2017

0.13

Fundamentals

Market Cap

AYTU:

$22.60M

PRGS:

$1.34B

EPS

AYTU:

-$2.91

PRGS:

$1.95

PS Ratio

AYTU:

0.44

PRGS:

1.39

PB Ratio

AYTU:

0.64

PRGS:

2.70

Total Revenue (TTM)

AYTU:

$56.60M

PRGS:

$987.62M

Gross Profit (TTM)

AYTU:

$36.14M

PRGS:

$802.40M

EBITDA (TTM)

AYTU:

-$27.34M

PRGS:

$136.06M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AYTU vs. PRGS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AYTU
AYTU Risk / Return Rank: 4949
Overall Rank
AYTU Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
AYTU Sortino Ratio Rank: 4747
Sortino Ratio Rank
AYTU Omega Ratio Rank: 4747
Omega Ratio Rank
AYTU Calmar Ratio Rank: 5050
Calmar Ratio Rank
AYTU Martin Ratio Rank: 5151
Martin Ratio Rank

PRGS
PRGS Risk / Return Rank: 88
Overall Rank
PRGS Sharpe Ratio Rank: 55
Sharpe Ratio Rank
PRGS Sortino Ratio Rank: 66
Sortino Ratio Rank
PRGS Omega Ratio Rank: 66
Omega Ratio Rank
PRGS Calmar Ratio Rank: 1111
Calmar Ratio Rank
PRGS Martin Ratio Rank: 1212
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AYTU vs. PRGS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aytu BioPharma, Inc. (AYTU) and Progress Software Corporation (PRGS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AYTUPRGSDifference
Sharpe ratioReturn per unit of total volatility

+1.22

Sortino ratioReturn per unit of downside risk

+2.19

Omega ratioGain probability vs. loss probability

1.08

0.81

+0.27

Calmar ratioReturn relative to maximum drawdown

0.29

-0.82

+1.11

Martin ratioReturn relative to average drawdown

0.68

-1.30

+1.97

AYTU vs. PRGS - Sharpe Ratio Comparison

The current AYTU Sharpe Ratio is 0.19, which is higher than the PRGS Sharpe Ratio of -1.03. The chart below compares the historical Sharpe Ratios of AYTU and PRGS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AYTU vs. PRGS - Drawdown Comparison

The maximum AYTU drawdown since its inception was -100.00%, which is greater than PRGS's maximum drawdown of -67.33%. Use the drawdown chart below to compare losses from any high point for AYTU and PRGS.


Loading charts...

Drawdown Indicators


AYTUPRGSDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-67.33%

-32.67%

Max Drawdown (1Y)

Largest decline over 1 year

-35.47%

-61.14%

+25.67%

Max Drawdown (3Y)

Largest decline over 3 years

-70.24%

-64.10%

-6.14%

Max Drawdown (5Y)

Largest decline over 5 years

-99.12%

-64.10%

-35.02%

Max Drawdown (10Y)

Largest decline over 10 years

-64.10%

Current Drawdown

Current decline from peak

-100.00%

-54.97%

-45.03%

Average Drawdown

Average peak-to-trough decline

-95.26%

-23.57%

-71.69%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.16%

38.81%

-23.65%

Volatility

AYTU vs. PRGS - Volatility Comparison

The current volatility for Aytu BioPharma, Inc. (AYTU) is 12.94%, while Progress Software Corporation (PRGS) has a volatility of 14.81%. This indicates that AYTU experiences smaller price fluctuations and is considered to be less risky than PRGS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AYTUPRGSDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.94%

14.81%

-1.87%

Volatility (6M)

Calculated over the trailing 6-month period

33.57%

41.69%

-8.12%

Volatility (1Y)

Calculated over the trailing 1-year period

54.47%

48.89%

+5.58%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

85.63%

33.42%

+52.21%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

188.01%

33.17%

+154.84%

Dividends

AYTU vs. PRGS - Dividend Comparison

Neither AYTU nor PRGS has paid dividends to shareholders.


PositionTTM2025202420232022202120202019201820172016
AYTU
Aytu BioPharma, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PRGS
Progress Software Corporation
0.00%0.00%0.81%1.29%1.39%1.45%1.48%1.52%1.62%1.21%0.39%

Financials

AYTU vs. PRGS - Financials Comparison

This section allows you to compare key financial metrics between Aytu BioPharma, Inc. and Progress Software Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M20222023202420252026
12.41M
247.80M
(AYTU) Total Revenue
(PRGS) Total Revenue
Values in USD except per share items

AYTU vs. PRGS - Profitability Comparison

The chart below illustrates the profitability comparison between Aytu BioPharma, Inc. and Progress Software Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
61.2%
82.3%
Portfolio components
AYTU - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported a gross profit of 7.60M and revenue of 12.41M. Therefore, the gross margin over that period was 61.2%.

PRGS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Progress Software Corporation reported a gross profit of 203.94M and revenue of 247.80M. Therefore, the gross margin over that period was 82.3%.

AYTU - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported an operating income of -4.06M and revenue of 12.41M, resulting in an operating margin of -32.8%.

PRGS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Progress Software Corporation reported an operating income of 46.47M and revenue of 247.80M, resulting in an operating margin of 18.8%.

AYTU - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported a net income of -5.62M and revenue of 12.41M, resulting in a net margin of -45.3%.

PRGS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Progress Software Corporation reported a net income of 22.81M and revenue of 247.80M, resulting in a net margin of 9.2%.


Frequently Asked Questions


AYTU and PRGS have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PRGS has higher volatility (14.81%) compared to AYTU (12.94%). In terms of maximum drawdown, AYTU dropped -100.00% vs PRGS's -67.33%.

AYTU currently has the higher Sharpe Ratio (0.19 vs -1.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AYTU and PRGS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer